Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study

By Isik AZ   Caglar GS   Sozen E   Akarsu C   Tuncay G   Ozbıcer T   Vicdan K  

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 472-477

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment

By Roulier Roger   Chabert-Orsini Véronique   Sitri Marie-Christine   Barry Bernard   Terriou P  

Reproductive BioMedicine Online, Vol. 7, Iss. 2, 2003-09 ,pp. : 185-189

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol

By Humaidan P   Bungum L   Bungum M   Hald F   Agerholm I   Blaabjerg J   Andersen C Yding   Lindenberg S  

Reproductive BioMedicine Online, Vol. 11, Iss. 6, 2005-12 ,pp. : 679-684

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist

By Garcia-Velasco JA   Coelingh Bennink HJT   Epifanio R   Escudero E   Pellicer A   Simón C  

Reproductive BioMedicine Online, Vol. 15, Iss. 3, 2007-09 ,pp. : 280-287

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Prospective comparison of short and long GnRH agonist protocols using recombinant gonadotrophins for IVF/ICSI treatments

By Ho Chi-Hong   Chen Shee-Uan   Peng Fu-Shiang   Chang Chih-Yuan   Lien Yih-Ron   Yang Yu-Shih  

Reproductive BioMedicine Online, Vol. 16, Iss. 5, 2008-05 ,pp. : 632-639

Reproductive Healthcare Ltd

Access to resources Recommend Favorite